125 related articles for article (PubMed ID: 26720004)
1. Bay 61-3606 Sensitizes TRAIL-Induced Apoptosis by Downregulating Mcl-1 in Breast Cancer Cells.
Kim SY; Park SE; Shim SM; Park S; Kim KK; Jeong SY; Choi EK; Hwang JJ; Jin DH; Chung CD; Kim I
PLoS One; 2015; 10(12):e0146073. PubMed ID: 26720004
[TBL] [Abstract][Full Text] [Related]
2. Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism.
Ortiz-Ferrón G; Yerbes R; Eramo A; López-Pérez AI; De Maria R; López-Rivas A
Cell Res; 2008 Jun; 18(6):664-76. PubMed ID: 18458681
[TBL] [Abstract][Full Text] [Related]
3. HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in colorectal cancer cells.
Lee DH; Sung KS; Bartlett DL; Kwon YT; Lee YJ
Cell Signal; 2015 Feb; 27(2):293-305. PubMed ID: 25446253
[TBL] [Abstract][Full Text] [Related]
4. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.
Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA
Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625
[TBL] [Abstract][Full Text] [Related]
5. The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells.
Song P; Yang S; Hua H; Zhang H; Kong Q; Wang J; Luo T; Jiang Y
J Biol Chem; 2019 Apr; 294(15):5945-5955. PubMed ID: 30782845
[TBL] [Abstract][Full Text] [Related]
6. Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation.
Lirdprapamongkol K; Sakurai H; Abdelhamed S; Yokoyama S; Athikomkulchai S; Viriyaroj A; Awale S; Ruchirawat S; Svasti J; Saiki I
Int J Oncol; 2013 Jul; 43(1):329-37. PubMed ID: 23636231
[TBL] [Abstract][Full Text] [Related]
7. Emetine enhances the tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of pancreatic cancer cells by downregulation of myeloid cell leukemia sequence-1 protein.
Han Y; Park S; Kinyua AW; Andera L; Kim KW; Kim I
Oncol Rep; 2014 Jan; 31(1):456-62. PubMed ID: 24213797
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of Mcl-1 by daunorubicin pretreatment reverses resistance of breast cancer cells to TNF-related apoptosis-inducing ligand.
Oh B; Park S; Pak JH; Kim I
Biochem Biophys Res Commun; 2012 May; 422(1):42-7. PubMed ID: 22554523
[TBL] [Abstract][Full Text] [Related]
9. The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006.
Yu C; Bruzek LM; Meng XW; Gores GJ; Carter CA; Kaufmann SH; Adjei AA
Oncogene; 2005 Oct; 24(46):6861-9. PubMed ID: 16007148
[TBL] [Abstract][Full Text] [Related]
10. Clitocine potentiates TRAIL-mediated apoptosis in human colon cancer cells by promoting Mcl-1 degradation.
Sun JG; Ruan F; Zeng XL; Xiang J; Li X; Wu P; Fung KP; Liu FY
Apoptosis; 2016 Oct; 21(10):1144-57. PubMed ID: 27421828
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of MEK sensitizes gastric cancer cells to TRAIL-induced apoptosis.
Wu P; Cheng YW; Wang JY; Zhang XD; Zhang LJ
Neoplasma; 2014; 61(2):136-43. PubMed ID: 24299309
[TBL] [Abstract][Full Text] [Related]
12. Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway.
Dong Y; Yin S; Li J; Jiang C; Ye M; Hu H
Apoptosis; 2011 Apr; 16(4):394-403. PubMed ID: 21259053
[TBL] [Abstract][Full Text] [Related]
13. Metformin enhances TRAIL-induced apoptosis by Mcl-1 degradation via Mule in colorectal cancer cells.
Park SH; Lee DH; Kim JL; Kim BR; Na YJ; Jo MJ; Jeong YA; Lee SY; Lee SI; Lee YY; Oh SC
Oncotarget; 2016 Sep; 7(37):59503-59518. PubMed ID: 27517746
[TBL] [Abstract][Full Text] [Related]
14. Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.
Ricci MS; Kim SH; Ogi K; Plastaras JP; Ling J; Wang W; Jin Z; Liu YY; Dicker DT; Chiao PJ; Flaherty KT; Smith CD; El-Deiry WS
Cancer Cell; 2007 Jul; 12(1):66-80. PubMed ID: 17613437
[TBL] [Abstract][Full Text] [Related]
15. The sesquiterpene lactone eupatolide sensitizes breast cancer cells to TRAIL through down-regulation of c-FLIP expression.
Lee J; Hwangbo C; Lee JJ; Seo J; Lee JH
Oncol Rep; 2010 Jan; 23(1):229-37. PubMed ID: 19956887
[TBL] [Abstract][Full Text] [Related]
16. FTY720 enhances TRAIL-mediated apoptosis by up-regulating DR5 and down-regulating Mcl-1 in cancer cells.
Woo SM; Seo BR; Min KJ; Kwon TK
Oncotarget; 2015 May; 6(13):11614-26. PubMed ID: 25843953
[TBL] [Abstract][Full Text] [Related]
17. Galangin sensitizes TRAIL-induced apoptosis through down-regulation of anti-apoptotic proteins in renal carcinoma Caki cells.
Han MA; Lee DH; Woo SM; Seo BR; Min KJ; Kim S; Park JW; Kim SH; Choi YH; Kwon TK
Sci Rep; 2016 Jan; 6():18642. PubMed ID: 26725939
[TBL] [Abstract][Full Text] [Related]
18. Mitotic arrest and JNK-induced proteasomal degradation of FLIP and Mcl-1 are key events in the sensitization of breast tumor cells to TRAIL by antimicrotubule agents.
Sánchez-Pérez T; Ortiz-Ferrón G; López-Rivas A
Cell Death Differ; 2010 May; 17(5):883-94. PubMed ID: 19942932
[TBL] [Abstract][Full Text] [Related]
19. Notch inhibition restores TRAIL-mediated apoptosis via AP1-dependent upregulation of DR4 and DR5 TRAIL receptors in MDA-MB-231 breast cancer cells.
Portanova P; Notaro A; Pellerito O; Sabella S; Giuliano M; Calvaruso G
Int J Oncol; 2013 Jul; 43(1):121-30. PubMed ID: 23686163
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation.
Sun NK; Huang SL; Chang TC; Chao CC
J Cell Biochem; 2013 Aug; 114(8):1819-31. PubMed ID: 23463670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
